Viewing data from:

PRUCALOPRIDE SUCCINATE

ANDA

PRUCALOPRIDE SUCCINATE | A217662 | HIKMA PHARMACEUTICALS USA INC

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: MOTEGRITY(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 2 NDCs

Highest NADAC/Unit

$0.6574

per ea

Lowest NADAC/Unit

$0.6528

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00054075013PRUCALOPRIDE 2 MG TABLET	$0.6574	EA	Generic	—	2026-08-19
00054074913PRUCALOPRIDE 1 MG TABLET	$0.6528	EA	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain12 active DMFs

12 active API suppliers hold Drug Master Files for this ingredient.

SYMED LABS LTDPRUCALOPRIDE SUCCINATE

DMF 348622020

METROCHEM API PRIVATE LTDPRUCALOPRIDE SUCCINATE

DMF 349702020

SHILPA PHARMA LIFESCIENCES LTDPRUCALOPRIDE SUCCINATE

DMF 350382020

SS PHARMA LLCPRUCALOPRIDE SUCCINATE

DMF 367652022

MEDICHEM MANUFACTURING (MALTA) LTDPRUCALOPRIDE SUCCINATE

DMF 371812022

MSN LABORATORIES PRIVATE LTDPRUCALOPRIDE SUCCINATE

DMF 373012022

BIOPHORE INDIA PHARMACEUTICALS PVT LTDPRUCALOPRIDE SUCCINATE

DMF 375762022

ALEMBIC PHARMACEUTICALS LTDPRUCALOPRIDE SUCCINATE

DMF 379112023

TORRENT PHARMACEUTICALS LTDPRUCALOPRIDE SUCCINATE

DMF 380842023

SUN PHARMACEUTICAL INDUSTRIES LTDPRUCALOPRIDE SUCCINATE

DMF 388932023

ERYTHRO PHARMA PRIVATE LTDPRUCALOPRIDE SUCCINATE ACID INTERMIDIATE

DMF 391882024

APITORIA PHARMA PRIVATE LTDPRUCALOPRIDE SUCCINATE

DMF 408602025

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — EQ 1MG BASE

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jun 24, 2025

No patent or exclusivity listings for this strength.

#002 — EQ 2MG BASE

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jun 24, 2025